Fueled by a $2 million grant in 2008 from the state’s 21st Century Research and Technology Fund, the company recently began testing of a bone regeneration technology that uses nanostructured biomaterials to promote bone growth for patients at high risk of developing fractures, such as people suffering from osteoporosis or other disorders. Nanovis President and Chief Operating Officer Matt Hedrick says the technology will allow doctors to intervene before a bone fractures.
“For someone with osteoporosis, for example, there are bones in your body that physicians know have a high probability of breaking in the short term, but there’s not a lot they can do about it,” says Hedrick. “It takes a long time to treat bone using pharmaceutical agents… and sometimes, surgeons know the bone is going to break, but they just can’t treat it fast enough to prevent it from breaking.”
Nanovis, which also has a location at the Birck Nanotechnology Center at the Purdue Research Park in West Lafayette, is developing a bone regeneration material that features a nano-scale coating to help it incorporate better into existing tissue. The injectable material could be delivered locally to bones at high risk of breaking, allowing doctors to intervene more quickly and help the bones regenerate “from the inside out.”